Elite Pharmaceuticals
About:
Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.
Website: http://www.elitepharma.com
Twitter/X: elitepharma
Top Investors: Lincoln Park Capital Fund, Crede CapitalGroup
Description:
Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders. The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.
$7.51M
$10M to $50M
Northvale, New Jersey, United States
1996-01-01
51-100
2020-07-13
Public
© 2025 bioDAO.ai